Heerlen, NL, 06 December 2022 18:00 CEST
Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options.
Pursuant to commitments entered into prior to issuing the Offering Circular, DSM has in the period from 23 November up to 6 December, 2022, delivered 9,090 ordinary shares to employees in view of settling the exercise of an equivalent number of stock options granted under the respective DSM Incentive Plan (the exercise price of 6,750 stock options was €50.98, whereas the average exercise price of 2,340 stock options was €97.90). In the same period, DSM has delivered 7,668 ordinary shares in view of the vesting of an equivalent number of share units that have been granted subject to the terms of the respective DSM Incentive Plan. On the date hereof, the total number of issued and outstanding DSM ordinary shares is 173,072,337. As a consequence of the delivery included herein, the number of outstanding DSM ordinary shares increased by 0.0097%.
This is a press release by Koninklijke DSM N.V. (Royal DSM), pursuant to the provisions of Sections 13 paragraphs 1 and 2 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft) (the Decree) in connection with the public offer by Danube AG (to be renamed DSM-Firmenich AG) for all the issued and outstanding ordinary shares in the capital of DSM (the Exchange Offer). This press release does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities. This press release is not for general release, publication or distribution, in whole or in part, in or into, directly or indirectly, the United States or any other jurisdiction where such release, publication or distribution would violate applicable laws or regulations.
Senior Director External Communications
+31 45 578 2420
Vice-President Investor Relations
+31 45 578 2864